By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Retrotope 

4300 El Camino Real
Suite 201
Los Altos  California  94022  U.S.A.
Phone: 650-917-9256 Fax: n/a


SEARCH JOBS

Retrotope has created a new category of drug platform to preserve and restore mitochondrial health in degenerative diseases. The unique mechanism of Retrotope’s platform prevents cellular damage and recovers cellular function damaged by lipid peroxidation due to oxidative stress. Retrotope’s first product candidate, RT001, is being clinically tested in Friedreich’s ataxia (FA), a high value untreated fatal orphan disease. Retrotope’s transformational platform technology of stabilized lipid drugs has the potential to treat a wide variety of other mitochondrial myopathies, but also show promise for diseases such as Parkinson’s, Alzheimer’s, diabetic retinopathy, and others.

YEAR FOUNDED:

2006

LEADERSHIP:

Founder and CEO: Robert J. Molinari

Founder and CSO: Mikhail S. Shchepinov

JOBS:

Please click here for Retrotope job opportunities.


Key Statistics


Email: info@retrotope.com
Ownership: Private

Web Site: Retrotope
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->